ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,872Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 1171

$455K Total Retail Price of All Prescriptions

Rank: 256 out of 1171

263 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 263 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 263 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 399 340 1 1
AMLODIPINE BESYLATE 300 226 2 2
MIRTAZAPINE 263 239 3 50
FUROSEMIDE 250 206 4 6
OMEPRAZOLE 248 206 5 5
JANTOVEN 237 231 6 147
LISINOPRIL 235 189 7 3
LEVOTHYROXINE SODIUM 217 215 8 4
METOPROLOL TARTRATE 163 145 9 11
POTASSIUM CHLORIDE 159 123 10 19
HYDROCODONE-ACETAMINOPHEN 155 110 S3 11 8
SANTYL 131 108 12 173
LANTUS 111 87 13 46
GABAPENTIN 110 74 14 16
POLYETHYLENE GLYCOL 3350 109 97 15 72
CARVEDILOL 107 81 16 20
CLONIDINE HCL 100 69 17 45
FAMOTIDINE 100 73 17 75
ZOLPIDEM TARTRATE 99 66 19 21
HYDRALAZINE HCL 97 48 20 60
DONEPEZIL HCL 80 80 21 24
HYDROCHLOROTHIAZIDE 78 47 22 9
CLOPIDOGREL 73 34 23 35
GLIPIZIDE 73 71 23 47
TRAMADOL HCL 73 58 23 18
RANITIDINE HCL 71 61 26 38
PLAVIX 70 36 27 55
BACLOFEN 67 20 28 110
NOVOLOG 64 55 29 94
DIOVAN 62 48 30 32
ENDOCET 60 53 S2 31 161
TRAZODONE HCL 60 38 31 37
PRAVASTATIN SODIUM 57 54 33 13
NAMENDA 57 57 33 42
SERTRALINE HCL 54 52 35 23
PREDNISONE 52 50 36 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.